Vident Investment Advisory, LLC Genetron Holdings LTD Transaction History

Vident Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$2.19 - $6.09 $18,297 - $50,881	8,355 Added 61.47%	21,947 $48,000
Q4 2021 Feb 14, 2022	SELL	$5.81 - $14.39 $20,793 - $51,501	-3,579 Reduced 20.84%	13,592 $83,000
Q3 2021 Nov 12, 2021	BUY	$11.55 - $20.3 $198,325 - $348,571	17,171 New	17,171 $238,000
Q2 2021 Aug 13, 2021	SELL	$17.9 - $23.29 $172,448 - $224,375	-9,634 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$13.71 - $30.64 $114,725 - $256,395	-8,368 Reduced 46.48%	9,634 $207,000
Q3 2020 Nov 12, 2020	BUY	$9.1 - $15.81 $163,818 - $284,611	18,002 New	18,002 $215,000

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.